Matches in Wikidata for { <http://www.wikidata.org/entity/Q65383258> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q65383258 description "clinical trial" @default.
- Q65383258 description "ensayu clínicu" @default.
- Q65383258 description "klinisch onderzoek" @default.
- Q65383258 description "клінічне випробування" @default.
- Q65383258 name "A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes" @default.
- Q65383258 name "A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes" @default.
- Q65383258 type Item @default.
- Q65383258 label "A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes" @default.
- Q65383258 label "A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes" @default.
- Q65383258 prefLabel "A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes" @default.
- Q65383258 prefLabel "A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes" @default.
- Q65383258 P1050 Q65383258-778FD192-73A2-45D3-9EFC-BB519B922B55 @default.
- Q65383258 P1132 Q65383258-389BF7EF-4E22-418F-8E5B-0419CE068F73 @default.
- Q65383258 P1476 Q65383258-A59B6D07-DAF5-4239-8AAB-6808D65933B4 @default.
- Q65383258 P17 Q65383258-D480A14B-5CCE-426C-A9C5-70A2FDE50CF3 @default.
- Q65383258 P2899 Q65383258-3B6412F0-F8DD-4DB5-A973-E27325EEEAD0 @default.
- Q65383258 P3098 Q65383258-6BEF1F4F-97B1-4E22-944C-FAEFFF05CD6E @default.
- Q65383258 P31 Q65383258-5195065D-194F-4014-BFEF-259D4C4FEFA1 @default.
- Q65383258 P4135 Q65383258-E36FFAE0-3F4E-43D2-B171-7ABAE108C94F @default.
- Q65383258 P4844 Q65383258-977F9CC4-8BC7-4697-8FA3-9F7E5E77292A @default.
- Q65383258 P4844 Q65383258-BBF07980-949E-43A0-A8E8-6CDA540C844A @default.
- Q65383258 P580 Q65383258-55E07467-52B1-4785-8AAA-483E56F879E2 @default.
- Q65383258 P582 Q65383258-AFA8D508-2CC8-4848-957A-71999665D03A @default.
- Q65383258 P6099 Q65383258-229A07AB-6891-4487-BD3A-45AA11ECA6DE @default.
- Q65383258 P8363 Q65383258-4DFE4115-70CF-4511-9C98-ABD591A6338E @default.
- Q65383258 P1050 Q12206 @default.
- Q65383258 P1132 "+112" @default.
- Q65383258 P1476 "A Phase 4, Randomized, Open Label, Parallel Group, Multicenter Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes" @default.
- Q65383258 P17 Q30 @default.
- Q65383258 P2899 "+18" @default.
- Q65383258 P3098 "NCT00467649" @default.
- Q65383258 P31 Q30612 @default.
- Q65383258 P4135 "+75" @default.
- Q65383258 P4844 Q2062094 @default.
- Q65383258 P4844 Q6042242 @default.
- Q65383258 P580 "2007-05-01T00:00:00Z" @default.
- Q65383258 P582 "2008-04-01T00:00:00Z" @default.
- Q65383258 P6099 Q42825046 @default.
- Q65383258 P8363 Q78089383 @default.